Related Experiment Video
Updated: Jul 19, 2026
14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Exercise-induced asthma in the competitive cold weather athlete.
1Duluth Clinic Orthopedics Department, 400 East 3rd Street, Duluth, MN 55805, USA. jbutcher@smdc.org
Current Sports Medicine Reports
|October 28, 2006
Summary
Winter athletes commonly experience exercise-induced asthma (EIA), often caused by dry air and rapid breathing. Objective testing methods and readily available treatments exist, but require careful management due to anti-doping regulations.
Area of Science:
- Sports Medicine
- Pulmonology
- Exercise Physiology
Background:
- Exercise-induced asthma (EIA) significantly impacts winter sport athletes, with prevalence rates reaching 50%.
- Key contributing factors to EIA in athletes include exposure to extremely low humidity and high respiratory rates during exercise.
- These environmental and physiological conditions lead to significant airway drying, a primary cause of EIA.
Purpose of the Study:
- To review recent advancements in objective testing methodologies for diagnosing exercise-induced asthma.
- To provide an overview of current treatment options for EIA in athletes.
- To highlight the importance of adhering to anti-doping regulations when prescribing medications for EIA.
Main Methods:
- Review of newly developed objective testing procedures for exercise-induced asthma.
- Analysis of current therapeutic strategies, including oral and inhaled medications.
- Examination of anti-doping agency regulations concerning EIA medications.
Main Results:
- New objective testing methods for EIA have been recently developed and are discussed.
- Effective oral and inhaled medications are available for treating EIA.
- Strict adherence to anti-doping regulations is crucial for athletes using EIA medications.
Conclusions:
- Exercise-induced asthma is a prevalent condition in winter sports, driven by airway drying from environmental factors.
- Objective testing and pharmacological treatments for EIA are established, but require careful consideration of doping regulations.
- Physicians must ensure athlete compliance with evolving anti-doping restrictions when managing EIA.
Related Concept Videos
01:29Asthma-I: Introduction
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
01:28Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
01:20Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:13Asthma III: Clinical Manifestations
Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
01:24Asthma-III: Symptoms and Complications
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma